Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
Journal of Analytical Toxicology|November 18, 2025
The Acute and Chronic Pharmacokinetic Oral Fluid Profile of Oral Cannabidiol (CBD) With and Without Low Doses of Delta-9-Tetrahydrocannabinol (Δ9-THC) in Healthy Human VolunteersSvante Vikingsson, C Austin Zamarripa, Tory R Spindle, et al.
Environmental Epigenetics|September 24, 2021
Refraining from use diminishes cannabis-associated epigenetic changes in human spermRose Schrott, Susan K Murphy, Jennifer L Modliszewski, et al.
Drug and Alcohol Dependence|September 5, 2025
Craving for opioid and cannabis use among adults with chronic pain: Insights from a 30-day ecological momentary assessment studyJennifer D Ellis, Ashley E Chipoletti, Siny Tsang, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|November 21, 2020
An Evaluation of Potential Unintended Consequences of a Nicotine Product Standard: A Focus on Drinking History and OutcomesSarah S Dermody, Katelyn M Tessier, Ellen Meier, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|December 24, 2019
The Impact of Gradual and Immediate Nicotine Reduction on Subjective Cigarette RatingsTracy T Smith, Eric C Donny, Xianghua Luo, et al.
International Psychogeriatrics|January 31, 2025
Study rationale and baseline data for pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's dementia (THC-AD)Leah M Cohen, Eleanor Ash, John D Outen, et al.
BMJ Open|May 21, 2020
Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder ('CANSLEEP' trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trialAnastasia Suraev, Ronald R Grunstein, Nathaniel S Marshall, et al.
International Psychogeriatrics|October 11, 2021
Study rationale and baseline data for pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's dementia (THC-AD)Leah M Cohen, Eleanor Ash, John D Outen, et al.
Tobacco Control|July 24, 2017
Perceived nicotine content of reduced nicotine content cigarettes is a correlate of perceived health risksLauren R Pacek, F Joseph McClernon, Rachel L Denlinger-Apte, et al.
Preventive Medicine|July 23, 2022
Smoking abstinence and cessation-related outcomes one month after an immediate versus gradual reduction in nicotine content of cigarettesElias M Klemperer, Xianghua Luo, Joni Jensen, et al.
Pageof 15